Northwest Biotherapeutics, Inc.

NWBO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q Aug 14, 2026 10-Q
8-K Jul 31, 2026 FORM 8-K
424B5 Jul 31, 2026 424B5
8-K Jul 20, 2026 FORM 8-K
10-Q May 15, 2026 10-Q
EFFECT Apr 20, 2026
POS AM Apr 16, 2026 POS AM
10-K Apr 15, 2026 10-K
8-K Apr 7, 2026 FORM 8-K
NT 10-K Mar 31, 2026 NT 10-K
8-K Jan 15, 2026 FORM 8-K
8-K Jan 2, 2026 FORM 8-K
DEF 14A Nov 28, 2025 FORM DEF 14A
EFFECT Nov 25, 2025
424B5 Nov 25, 2025 424B5
CORRESP Nov 24, 2025
8-K Nov 20, 2025 FORM 8-K
PRE 14A Nov 19, 2025 FORM PRE 14A
10-Q Nov 14, 2025 10-Q
8-K Oct 31, 2025 FORM 8-K
8-K Oct 30, 2025 FORM 8-K
8-K Oct 24, 2025 FORM 8-K
S-3 Oct 24, 2025 FORM S-3
8-K Oct 14, 2025 FORM 8-K
10-Q Aug 14, 2025 10-Q
← Newer Page 1 of 33 · 802 filings Older →